Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...
5don MSN
Insurance data can help fill gaps between longer medical trials for patients up against the clock
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
News-Medical.Net on MSN
AI language models actually help in digestive disease care
Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback